Influence of Skin Commensals on Therapeutic Outcomes of Surgically Debrided Diabetic Foot Infections—A Large Retrospective Comparative Study

Influence of Skin Commensals on Therapeutic Outcomes of Surgically Debrided Diabetic Foot Infections—A Large Retrospective Comparative Study

In diabetic foot infections (DFI), the clinical virulence of skin commensals are generally presumed to be low. In this single-center study, we divided the wound isolates into two groups: skin commensals (coagulase-negative staphylococci, micrococci, corynebacteria, cutibacteria) and pathogenic patho...

Full description

Bibliographic Details
Main Authors:	Ilker Uçkay, Dan Lebowitz, Benjamin Kressmann, Benjamin A. Lipsky, Karim Gariani
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Antibiotics
Subjects:	antibiotic therapy diabetic foot infections non-beta-lactam antibiotics skin commensals treatment failures associations with treatment failure
Online Access:	https://www.mdpi.com/2079-6382/12/2/316

Similar Items

Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection?
by: Dan Lebowitz, et al.
Published: (2017-06-01)

Treating Diabetic Foot Osteomyelitis: A Practical State-of-the-Art Update
by: Benjamin A. Lipsky, et al.
Published: (2021-04-01)

Therapy for Non-Diabetic Foot Infections After Orthopedic Foot and Ankle Surgery: The Duration of Post-Debridement Antibiotic Treatment Does Not Alter Failure Risk
by: Martina Scherer, et al.
Published: (2024-11-01)

Strategies for Clarifying Penicillin Allergies When Skin Testing Is Not an Option
by: Elizabeth W. Covington, et al.
Published: (2019-06-01)

Evaluation of determination of 6-aminopenicillanic acid by p-dimethyl aminobenzaldehyde /
by: 408833 Shewale, Jaiprakash G., et al.

Biochemistry of peptide antibiotics : recent advances in the biotechnology of beta-lactams and microbial bioactive peptides /
by: Kleinkauf, Horst, et al.
Published: (1990)

Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G
by: Raquel Simbalista, et al.
Published: (2011-01-01)

The biosynthesis of β-lactams
by: Goh, K, et al.
Published: (1993)

Historical Review of the Penicillin and Related Compounds (β – Lactams)
by: Luma Salman Abd
Published: (2018-06-01)

Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
by: Dominique Altmann, et al.
Published: (2023-03-01)

Mechanism and yields in enzyme catalysed equilibrium and kinetically controlled synthesis of beta-lactam antibiotics, peptides and other condensation products /
by: 416857 Kasche, Volker

Enzymatic synthesis of ampicillin : a chemometric optimization /
by: Boccu, Enrico

Cellulitis: when to say its treatment failure
by: Sadaf Sheikh
Published: (2023-01-01)

Local Antibiotics in the Treatment of Diabetic Foot Infections: A Narrative Review
by: Laura Soldevila-Boixader, et al.
Published: (2023-01-01)

Expression of bovine annexin A4 in E. coli rescues cytokinesis blocked by beta-lactam antibiotics
by: Carl E. Creutz
Published: (2023-12-01)

Antibiotic-Related Adverse Drug Reactions in Patients Treated on the Dermatology Ward of Medical University of Gdańsk
by: Ewa Maria Sokolewicz, et al.
Published: (2021-09-01)

Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
by: W. R. P. L. I. Wijesooriya, et al.
Published: (2017-10-01)

The protective role of commensal gut microbes and their metabolites against bacterial pathogens
by: Liqin Cheng, et al.
Published: (2024-12-01)

Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations
by: Darren J. Bentley
Published: (2024-04-01)

The association of chronic, enhanced immunosuppression with outcomes of diabetic foot infections
by: Ilker Uçkay, et al.
Published: (2022-01-01)

Preoperative Antibiotic Administration Does Not Improve the Outcomes of Operated Diabetic Foot Infections
by: Thaddaeus Muri, et al.
Published: (2024-11-01)

Geographical and Ethnic Differences Influence Culturable Commensal Yeast Diversity on Healthy Skin
by: Cheryl Leong, et al.
Published: (2019-08-01)

The Commensal Microbiota and Viral Infection: A Comprehensive Review
by: Na Li, et al.
Published: (2019-07-01)

Towards defining mechanisms involved in β-lactam resistance using serial crystallography
by: Lucic, A
Published: (2021)

Acute kidney injury induced by beta-lactam antibiotics in children: A scoping review
by: Astalitha Lorel Tania, et al.
Published: (2024-07-01)

Meropenem/Vaborbactam—A Mechanistic Review for Insight into Future Development of Combinational Therapies
by: Trae Hillyer, et al.
Published: (2024-05-01)

Extended Infusion of Beta-Lactams and Glycopeptides: A New Era in Pediatric Care? A Systematic Review and Meta-Analysis
by: Andrea Rahel Burch, et al.
Published: (2024-02-01)

Investigation of Beta-lactam Group Antibiotics Residue in Raw Cow Milk in Sivas Province
by: Nazlı Ercan, et al.
Published: (2022-12-01)

The Epidemiology of Antibiotic-Related Adverse Events in the Treatment of Diabetic Foot Infections: A Narrative Review of the Literature
by: Laura Soldevila-Boixader, et al.
Published: (2023-04-01)

A case report: Navigating chronic Actinomyces (“Madura foot”) infection in a 36-year-old patient - A surgical dilemma and long-term strategy
by: Beshoy W. Khalil, MD, DPM, AACFAS, et al.
Published: (2024-01-01)

SYN-007, an Orally Administered Beta-Lactamase Enzyme, Protects the Gut Microbiome from Oral Amoxicillin/Clavulanate without Adversely Affecting Antibiotic Systemic Absorption in Dogs
by: Sheila Connelly, et al.
Published: (2020-01-01)

Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group
by: Joyce de Souza, et al.
Published: (2024-05-01)

Systemic Antimicrobial Therapy for Diabetic Foot Infections: An Overview of Systematic Reviews
by: Angela Wright, et al.
Published: (2023-06-01)

Defining the Benefits of Antibiotic Resistance in Commensals and the Scope for Resistance Optimization
by: Kristofer Wollein Waldetoft, et al.
Published: (2023-02-01)

The state and consideration for skin test of β-lactam antibiotics in pediatrics
by: Chunhui Gao, et al.
Published: (2023-06-01)

Plasmid Curing of Bacteria Isolated from Upper Respiratory Tract Infections among Patients Attending Specialist Hospital Sokoto
by: Gambo Saifullahi, et al.
Published: (2024-06-01)

Enantioselective synthesis of beta-amino acids /
by: Juaristi, Eusebio, et al.
Published: (2005)

Identifying the Molecular Fingerprint of Beta-Lactams via Raman/SERS Spectroscopy Using Unconventional Nanoparticles for Antimicrobial Stewardship
by: Vinicius Pereira Anjos, et al.
Published: (2024-12-01)

A Hunt for the Resistance of <i>Haemophilus influnezae</i> to Beta-Lactams
by: Mélanie Denizon, et al.
Published: (2024-08-01)

Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections
by: Richard C. Wilson, et al.
Published: (2024-07-01)